No device was received for analysis at the time of submission of the initial 3500a.Since the product was not returned for analysis, no product failure analysis can be conducted and no determination of possible contributing factors could be made.Device history record (dhr) review cannot be conducted because no lot number was provided by the customer.Concomitant products were used during this study: carto 3 system and a spiral diagnostic decapolar mapping lasso catheter.Other company¿s devices were used during this study: sl1 sheaths (st.Jude medical, (b)(4), usa).Method: no testing methods performed.Results: no results available since no evaluation performed.Conclusion: device discarded by user, unable to follow-up.(b)(4).The device was not returned to bwi.
|
This event is from a literature source.It was reported that one patient developed a pulmonary embolism, that lead to prolonged hospital stay >48 hours from noac group (group 2).Based on the facts of the case and the author's assessment, there were no reported malfunction with any of the bwi catheters and systems used during the case.Thus, this event is unrelated to the device and most likely related to the procedure.Title:apixaban, rivaroxaban, and dabigatran in patients undergoing atrial fibrillation ablation.The purpose of this study was to evaluate the periprocedural major complications (mc) of ca of af, and compared apixaban, dabigatran, and rivaroxaban with continuous phenoprocoumon.The study was conducted between (b)(6) 2013 and (b)(6) 2014.Suspected device is the thermocool navi-star, biosense webster catheter, however catalog and lot number are unknown.Should more information be received, product for this adverse event will be modified as appropriate.Concomitant products were used during this study: carto 3 system and a spiral diagnostic decapolar mapping lasso catheter.Other company's devices were used during this study: sl1 sheaths (st.Jude medical, (b)(6), usa).The awareness date for this complaint is 9/06/2016 because the article was reviewed on 09/6/2016.
|